2014 Comment Letters

AACC continually tracks legislative and regulatory issues of importance to clinical laboratories and the clinical laboratory profession. Recently we commented on a wide range of topics to federal and state authorities. For more information, contact AACC Government Affairs.

2014 Legislative and Regulatory Issues

AACC joined with the AMA and others in urging the FDA to use the rulemaking process when making changes to LDT policy


AACC wrote to key Senators urging them to permit a final vote on newborn screening legislation


AACC joined with other health care groups in urging HRSA to provide greater recognition to the Allied Health and Laboratory professions


AACC urges IOM to address ‘harmonization’ in its forthcoming study on “Diagnostic Error in Health Care”


AACC urges NYS to rescind directive on use POCT blood glucose monitors in hospitals until federal agencies final policies


AACC requests CMS conduct an impact analysis study on new private market rate payment system on patient access to care


AACC joined with other health care provider in urging House leaders to schedule a vote on H.R.1281, the Newborn Screening Saves Lives Reauthorization Act


AACC provided comments to the FDA seeking changes to its draft guidance on the use of POCT blood glucose monitors in professional settings 


AACC joined with the Friends of AHRQ in supporting continued funding for the agency in FY'15 


AACC recommended report language for the harmonization of clinical laboratory test results 


AACC wrote Rep. Fred Upton (R-MI) opposing the President's proposed cuts in laboratory reimbursement 


AACC wrote to Senator Barbara Mikulski (D-MD) in support of continued federal funding for the National Children's Study 


AACC urged Senator Mary Landrieu (D-LA) to include report language in the Labor HHS Appropriations bill recognizing the need to harmonize laboratory test results 


AACC and the American Academy of Pain Management recommended the Medicare contractor Noridian pay for specimen validity testing 


AACC joined the Clinical Laboratory Coalition in opposing additional cuts in laboratory reimbursement 


AACC wrote FDA seeking clarification regarding aspects of its final RUO/IUO guidance